RxDoctor Payments Data

Bing Behrens, MD

Neurology · Jonesboro, ARNPI 1841256609

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,194 of the $5,302 with a category attached, or 79.1%. 21 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 27.5% of the total. Reporting peaked in 2024 at $2,032 and has fallen 58.3% since, to $848 in 2025.

$5,302in general payments, 2019–2025

Across 189 payments — averaging $28.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • AbbVie$1K
  • Harmony Biosciences LLC$533
  • Novartis$451
  • Amgen$403
  • Jazz Pharmaceuticals Inc.$371
  • plus $956 from 15 others

What the payments were for

  • Travel & lodging$85316%
  • Food & beverage$4,19479%
  • Education$2555%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,302 in reported general payments places this provider in the 65th percentile of 93 neurology providers in Arkansas.

See all neurology providers in Arkansas

Medicare billing

Part B allowed, 2024
$178,520
Medicare patients
447
Services billed
757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gamunex-CImmune Globul G/Gly/Iga Avg 4628$157,591
Modafinil18$503
Trazodone Hcl112$496
Gabapentin26$466
Eszopiclone27$462
Quetiapine Fumarate23$292
Ropinirole Hcl15$279
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine11$63
Zolpidem Tartrate12$35
Clonazepam23$25

Paid to pharmacies, not to this prescriber.

Other neurology in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →